Throat News and Research

RSS

A parent-to-parent campaign to get vaccine rates up

In 2017, Kim Nelson had just moved her family back to her hometown in South Carolina. Boxes were still scattered around the apartment, and while her two young daughters played, Nelson scrolled through a newspaper article on her phone.

25 Feb 2019

Cervical cancer could be eradicated by 2100

Scaling up the human papillomavirus (HPV) vaccine could eradicate cervical cancer in high-income countries within 30 years, according to a new study.

21 Feb 2019

Newly released national framework identifies obstacles to improving EMS systems

As part of nationwide efforts to improve emergency medical care, researchers at the Mount Sinai Health System, in collaboration with UC San Diego Health, have released a national framework report titled "Promoting Innovations in Emergency Medical Services" that identifies regulatory, financial, and technological obstacles to improving local and state EMS systems.

20 Feb 2019

Influenza and common cold are completely different diseases, study shows

There is a lack of information about the difference between influenza, "real" flu, and the common cold. Most people struggle to distinguish between these two diseases and this often leads to irritation and the perpetuation of myths.

19 Feb 2019

Scientists discover trigger that turns strep infections into devastating disease

Houston Methodist infectious disease scientists have discovered a previously unknown trigger that turns a relatively run-of-the-mill infection into a devastatingly ravenous, flesh-eating disease.

18 Feb 2019

Decolonization protocol after hospital discharge can prevent dangerous infections

Hospital patients who have methicillin-resistant Staphylococcus aureus can prevent future MRSA infections by following a standard bathing protocol after discharge, according to research results published in the February 14 issue of the New England Journal of Medicine.

15 Feb 2019

Mount Sinai awarded $12.5 million NIH grant for research program in aging biology

Researchers from the Icahn School of Medicine at Mount Sinai have been awarded a $12.5 million grant from the National Institute on Aging, part of the National Institutes of Health, for a five-year program called the U19 that consists of four multidisciplinary projects in aging biology.

14 Feb 2019

Misconceptions surrounding HPV are causing women to miss smear tests

A survey has found that a “concerning” level of misunderstanding and stigma surrounding HPV could be putting women off going for cervical smear tests.

13 Feb 2019

Social stigmas surrounding HPV could put women off going for cervical screening

The social stigmas and myths surrounding the human papilloma virus (HPV) could make women anxious, including raising fears about their partners' fidelity and putting them off going for cervical screening, according to research presented at Cancer Research UK's Early Diagnosis Conference in Birmingham today.

12 Feb 2019

Using Therapy Dogs to Reduce Stress and Improve Emotional Well-Being in Vulnerable Individuals

There is much research that shows that therapy dogs can help reduce stress and improve emotional well-being in vulnerable individuals. Rachel McPherson talks about this research that the work done by The Good Dog Foundation.

11 Feb 2019

Study explores patterns of adenoid and tonsil growth in teenagers

In the most thorough longitudinal study performed to date, X-ray images of children at five developmental stages between the ages of eight and nineteen were carefully measured.

11 Feb 2019

Prior dengue virus infection increases Zika virus-induced damage during pregnancy

Women who have previously been infected with dengue virus may be at risk for increased damage to their fetuses and placentas if they should later become infected with the Zika virus, researchers from the Department of Microbiology at the Icahn School of Medicine at Mount Sinai report.

11 Feb 2019

Increase in vocal-cord cancers among young adults appears to be the result of HPV infection

A remarkable recent increase in the diagnosis of vocal-cord cancer in young adults appears to be the result of infection with strains of human papilloma virus that also cause cervical cancer and other malignancies.

8 Feb 2019

New prostate cancer prediction tool has unmatched accuracy

A team of researchers from the Icahn School of Medicine at Mount Sinai and Keck School of Medicine at the University of Southern California have developed a novel machine-learning framework that distinguishes between low- and high-risk prostate cancer with more precision than ever before.

7 Feb 2019

High-risk sexually transmitted HPV may increase risk of cardiovascular disease

Infection with high-risk strains of the human papillomavirus, which have been linked to cancer, might increase the risk of heart and blood vessel or cardiovascular disease, especially among women with obesity or other cardiovascular risk factors, according to new research in Circulation Research, an American Heart Association journal.

7 Feb 2019

Measles warning in Western Australia

A measles warning has been issued in Western Australia after a passenger was diagnosed with the illness. The passenger was travelling with Singapore Airlines.

5 Feb 2019

Are Electronic Cigarettes Facilitating Illicit Drug Use?

In this interview, Dr. Michelle Peace provides an introduction to her research into the use of e-cigarettes for the inhalation of illicit drugs.

From Pittcon 5 Feb 2019

Vaping twice as good as gum for quitting smoking finds study

A new study has revealed that using e-cigarettes are twice as effective as chewing nicotine containing gum or using nicotine skin patches in quitting smoking. The results of the study were published in the latest issue of the New England Journal of Medicine (NEJM).

31 Jan 2019

E-cigarettes are almost twice as effective as nicotine replacement treatments, shows new study

E-cigarettes are almost twice as effective as nicotine replacement treatments, such as patches and gum, at helping smokers to quit, according to a clinical trial led by Queen Mary University of London.

30 Jan 2019

FDA approves first generic version of commonly prescribed asthma inhaler

The U.S. Food and Drug Administration today approved the first generic of Advair Diskus (fluticasone propionate and salmeterol inhalation powder) for the twice-daily treatment of asthma in patients aged four years and older and maintenance treatment of airflow obstruction and reducing exacerbations in patients with chronic obstructive pulmonary disease.

30 Jan 2019